64
Participants
Start Date
February 29, 2000
Primary Completion Date
September 30, 2008
Study Completion Date
December 31, 2008
rosiglitazone
Tablet taken orally at a dosage of 4 mg once per day and increase to twice per day if adequate glycemic control was not achieved. Study drug was taken up to 3 years.
glyburide
Tablet taken orally, initially 2.5 mg in the morning or dose subject received prior to starting the study. Dosage was increased by 2.5 mg in the evening up to a maximum of 10 mg twice a day if necessary to achieve desired glycemic control. Study drug was taken up to 3 years.
DVA Puget Sound Health Care System, Seattle
Collaborators (1)
Seattle Institute for Biomedical and Clinical Research
OTHER
GlaxoSmithKline
INDUSTRY
University of Washington
OTHER